0 results available. Select is focused ,type to refine list, press Down to open the menu,
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating di...
The following section summarizes insights on Cytokinetics Inc's Enterprise Value (EV):
We've identified the following companies as similar to Cytokinetics Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Enterprise Value (EV) in the valuation category include:
Enterprise Value (EV), also referred to as Business Enterprise Value (BEV), reflects the market value of the entire business. Unlikely Total Enterpris...
Enterprise Value (EV), also referred to as Business Enterprise Value (BEV), reflects the market value of the entire business. In laymen’s terms, it’s the amount an acquirer would have to pay to buy a business. In valuation terms, enterprise value represents the market value of the company’s total operating assets.
How to calculate the Enterprise Value (EV)
Market Capitalization
(+) Total Debt
(+) Minority Interest and Other Liabilities
(+) Preferred Equity
(-) Cash And Short Term Investments
(-) Long Term Investments
(-) Other Adjustments
(=) Enterprise Value (EV)
Enterprise value is not meaningful for all companies. Banks and similar financial institutionals must operate with a lot of debt on their balance sheets in order to function, so equity value tends to be the more appropriate measure of business value.
Note, Enterprise Value differs from Total Enterprise Value (TEV) because non-operating assets are not deducted from TEV.
Since Cytokinetics is not such a financial institutional, we can calculate enterprise value as follows:
Market Capitalization [ $4.766 B ]
(+) Total Debt [ $923.2 M ]
(+) Minority Interest and Other Liabilities [ NA ]
(+) Preferred Equity [ NA ]
(-) Cash And Short Term Investments [ -$1.076 B ]
(-) Long Term Investments [ -$145.1 M ]
(-) Other Adjustments [ $0 T ]
(=) Enterprise Value (EV) (USD) [ $4.468 B ]
(x) FX Conversion Rate (USD/presentment) [ 1.00 ]
(=) Enterprise Value (EV) (presentment) [ 4.468 B ]
The tables below summarizes the trend in Cytokinetics’s Market Capitalization and Enterprise Value (EV) over the last five years:
| Date | Market Cap (USD) | Enterprise Value (EV) (USD) | |
|---|---|---|---|
| 2020-12-31 | $1.471 B | $1.16 B | |
| 2021-12-31 | $3.823 B | $3.421 B | |
| 2022-12-31 | $4.336 B | $4.181 B | |
| 2023-12-31 | $8.186 B | $8.381 B | |
| 2024-12-31 | $5.551 B | $4.468 B |
The chart above depicts the distribution of enterprise value (ev) for companies operating in the Healthcare sector in the Developed economic region. Over 2,500 companies were considered in this analysis, and 2,401 had meaningful values. The average enterprise value (ev) of companies in the sector is 1.193 B with a standard deviation of 4.149 B.
Cytokinetics Inc's Enterprise Value (EV) of 4.468 B ranks in the 92.9% percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 2,501 |
| Included Constituents | 2,401 |
| Min | -97.337 M |
| Max | 39.135 B |
| Median | 38.891 M |
| Mean | 1.193 B |
| Standard Deviation | 4.149 B |
You can find companies with similar enterprise value (ev) using this stock screener.